RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank56
Year-over-Year Change
Year-over-year total asset growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
2.91%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | 1.84% |
| Q4 2024 | 0.00% |
| Q3 2024 | -18.08% |
| Q2 2024 | 0.00% |
| Q1 2024 | -4.44% |
| Q4 2023 | 0.00% |
| Q3 2023 | -34.22% |
| Q2 2023 | -40.45% |
| Q1 2023 | -62.97% |
| Q4 2022 | 1.07% |
| Q3 2022 | -6.41% |
| Q2 2022 | 0.55% |
| Q1 2022 | -7.80% |
| Q4 2021 | -2.76% |
| Q3 2021 | -8.51% |
| Q2 2021 | -7.47% |
| Q1 2021 | 22.13% |
| Q4 2020 | 6.66% |
| Q3 2020 | 1.57% |
| Q2 2020 | 15.95% |
| Q1 2020 | 93.63% |
| Q4 2019 | 84.12% |
| Q3 2019 | -19.02% |
| Q2 2019 | -14.52% |
| Q1 2019 | -6.85% |
| Q4 2018 | 16.93% |
| Q3 2018 | 41.03% |
| Q2 2018 | -18.42% |
| Q1 2018 | -19.09% |
| Q4 2017 | 14.00% |
| Q3 2017 | -18.85% |
| Q2 2017 | -10.95% |
| Q1 2017 | -6.21% |
| Q4 2016 | 51.82% |
| Q3 2016 | -13.11% |
| Q2 2016 | -8.61% |
| Q1 2016 | -7.89% |
| Q4 2015 | -6.85% |
| Q3 2015 | 108.67% |